Preoperative factors | LAMA/LABA group (n = 19) | Control group (n = 17) | COPD group (n = 18) | p value | |
LAMA/LABA vs Control | COPD vs Control | ||||
Gender (male/female) | 9/10 | 2/15 | 18/0 | ||
Age (average) | 71.1 ± 10.4 | 65.2 ± 11.2 | 71.0 ± 5.3 | 0.0671 | 0.0731 |
Pathology | 0.1162 | 0.0026 | |||
Adenocarcinoma | 14 | 14 | 7 | ||
Squamous cell carcinoma | 4 | 10 | |||
Adenosquamous carcinoma | 2 | ||||
Pleomorphic carcinoma | 1 | 1 | |||
Small cell carcinoma | 1 | ||||
Left/right | 9/10 | 10/7 | 7/11 | ||
Upper/middle/middle-lower/lower lobes | 11/2/0/6 | 9/0/0/8 | 7/2/1/8 | ||
Clinical T-factor (T1/T2/T3) | 12/7/0 | 10/6/1 | 7/9/2 | ||
Clinical N-factor (N0/N1/N2) | 15/4/0 | 15/1/1 | 13/4/1 | ||
Clinical M-factor (M0/M1b) | 18/1 | 16/1 | 18/0 | ||
Clinical stage (IA/IB/IIA/IIB/IIIA/IIIB/IV) | 11/2/4/1/0/0/1 | 10/3/1/1/1/0/1 | 5/6/3/3/1/0/0 | ||
Pathological T-factor (T1/T2/T3) | 12/7/0 | 10/7/0 | 9/7/2 | ||
Pathological N-factor (N0/N1/N2) | 15/2/2 | 12/1/4 | 16/2/0 | ||
Pathological M-factor (M0/M1b) | 18/1 | 17/0 | 18/0 | ||
Pathological stage (IA/IB/IIA/IIB/IIIA/IIIB/IV) | 9/4/2/1/2/0/1 | 9/3/1/0/4/0/0 | 7/7/2/2/0/0/0 | ||
PaO2 (mmHg) | 83.5 ± 12.9 | 71.0 ±11.4 | 84.3 ± 11.1 | 0.1781 | 0.0370 |
PaCO2 (mmHg) | 39.9 ± 3.6 | 41.1 ± 2.6 | 40.5 ± 3.1 | 0.1781 | 0.0370 |
pH | 7.4 ± 0.0 | 7.4 ± 0.0 | 7.4 ± 0.0 | 0.1781 | 0.0370 |
Smoking history | 7 | 7 | 17 | ||
Brinkman index | 1079 ± 613 | 549 ± 435 | 1284 ± 881 | 0.1781 | 0.0370 |